Form 4: Regal Rexnord EVP and CFO Robert Rehard Acquires Additional Shares Through Dividend Reinvestment
SEC Form 4 Filing
Robert Rehard, EVP and CFO of Regal Rexnord Corp, acquired additional common stock through a dividend equivalent reinvestment on April 12, 2024.
Summary
- On April 12, 2024, Robert Rehard, the Executive Vice President and Chief Financial Officer of Regal Rexnord Corp (RRX), acquired 12.565 shares of common stock at a price of $163.09 per share.
- This acquisition was a result of a dividend equivalent reinvestment related to his outstanding restricted stock unit awards.
- Following the transaction, Rehard directly owns 31,388.812 shares of Regal Rexnord Corp.
- Rehard also holds various stock appreciation rights (SARs) that are exercisable at different dates and prices, with expiration dates ranging from 2025 to 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by an executive is generally viewed as a positive sign, but the amount is relatively small and stems from dividend reinvestment, making it a routine transaction.
Positives
- The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Insider transactions are routinely monitored and reported to the SEC. They provide insights into management's perspective on the company's valuation and future prospects.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it involves a small number of shares acquired through dividend reinvestment.
Key Dates
| Date | Description |
|---|---|
| 05/12/2017 | Date of grant for stock appreciation rights with an exercise price of $74.56 and an expiration date of 05/12/2025. |
| 05/11/2018 | Date of grant for stock appreciation rights with an exercise price of $54.79 and an expiration date of 05/11/2026. |
| 05/10/2019 | Date of grant for stock appreciation rights with an exercise price of $76.99 and an expiration date of 05/10/2027. |
| 05/09/2020 | Date of grant for stock appreciation rights with an exercise price of $74.04 and an expiration date of 05/09/2028. |
| 05/08/2021 | Date of grant for stock appreciation rights with an exercise price of $78.05 and an expiration date of 05/08/2029. |
| 02/18/2021 | Date of grant for stock appreciation rights with an exercise price of $84.39 and an expiration date of 02/18/2030. |
| 02/23/2022 | Date of grant for stock appreciation rights with an exercise price of $133.77 and an expiration date of 02/23/2031. |
| 02/23/2023 | Date of grant for stock appreciation rights with an exercise price of $151.27 and an expiration date of 02/23/2032. |
| 02/23/2024 | Date of grant for stock appreciation rights with an exercise price of $154.2 and an expiration date of 02/23/2033. |
| 02/23/2025 | Date of grant for stock appreciation rights with an exercise price of $168.47 and an expiration date of 02/23/2034. |
| 04/12/2024 | Date of transaction: Robert Rehard acquired 12.565 shares of common stock at $163.09 per share. |
| 04/16/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.